Click here to get full coverage on YmAbs Therapeutics (YMAB) Surges 103.3%: Is This an Indication of Further Gains? - Yahoo Finance

YmAbs Therapeutics (YMAB) Surges 103.3%: Is This an Indication of Further Gains?  Yahoo Finance

YmAbs Therapeutics (YMAB) Surges 103.3%: Is This an Indication of Further Gains? - Yahoo Finance

Click here to get full coverage on $412M Acquisition: SERB Pharmaceuticals Buys Cancer Drug Maker Y-mAbs at 105% Premium - Stock Titan

$412M Acquisition: SERB Pharmaceuticals Buys Cancer Drug Maker Y-mAbs at 105% Premium  Stock Titan

$412M Acquisition: SERB Pharmaceuticals Buys Cancer Drug Maker Y-mAbs at 105% Premium - Stock Titan

Click here to get full coverage on Geopolitics Watch: Is YMAB backed by strong institutional buying - Quarterly Profit Summary & Low Risk Growth Stock Ideas - baoquankhu1.vn

Geopolitics Watch: Is YMAB backed by strong institutional buying - Quarterly Profit Summary & Low Risk Growth Stock Ideas  baoquankhu1.vn

Geopolitics Watch: Is YMAB backed by strong institutional buying - Quarterly Profit Summary & Low Risk Growth Stock Ideas - baoquankhu1.vn

Click here to get full coverage on Y-mAbs Therapeutics: Deal Showcases Value And Challenges Of Biotech M&A (YMAB) - Seeking Alpha

Y-mAbs Therapeutics: Deal Showcases Value And Challenges Of Biotech M&A (YMAB)  Seeking Alpha

Y-mAbs Therapeutics: Deal Showcases Value And Challenges Of Biotech M&A (YMAB) - Seeking Alpha

Click here to get full coverage on $YMAB stock is up 103% today. Here's what we see in our data. - Quiver Quantitative

$YMAB stock is up 103% today. Here's what we see in our data.  Quiver Quantitative

$YMAB stock is up 103% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Earnings Update: Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts - simplywall.st

Earnings Update: Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts  simplywall.st

Earnings Update: Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts - simplywall.st

Click here to get full coverage on Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy? - Yahoo Finance

Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy?  Yahoo Finance

Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy? - Yahoo Finance

Click here to get full coverage on Y-mAbs Therapeutics, Inc. (YMAB) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Y-mAbs Therapeutics, Inc. (YMAB) Reports Q2 Loss, Tops Revenue Estimates  Yahoo Finance

Y-mAbs Therapeutics, Inc. (YMAB) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on Y-mAbs Therapeutics to Present at Citi's 2024 Global Healthcare Conference - Stock Titan

Y-mAbs Therapeutics to Present at Citi's 2024 Global Healthcare Conference  Stock Titan

Y-mAbs Therapeutics to Present at Citi's 2024 Global Healthcare Conference - Stock Titan

Click here to get full coverage on Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance

Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on Y-mAbs Therapeutics (YMAB) Stock Price, News & Analysis - MarketBeat

Y-mAbs Therapeutics (YMAB) Stock Price, News & Analysis  MarketBeat

Y-mAbs Therapeutics (YMAB) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on YMAB - Y-Mabs Therapeutics Latest Stock News & Market Updates - Stock Titan

YMAB - Y-Mabs Therapeutics Latest Stock News & Market Updates  Stock Titan

YMAB - Y-Mabs Therapeutics Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Y-mAbs Appoints Seasoned Biopharma Executive Peter Pfreundschuh as Chief Financial Officer - Stock Titan

Y-mAbs Appoints Seasoned Biopharma Executive Peter Pfreundschuh as Chief Financial Officer  Stock Titan

YMAB

Price Chart

Key Statistics

Technicals

About YMAB

Latest News

YmAbs Therapeutics (YMAB) Surges 103.3%: Is This an Indication of Further Gains? - Yahoo Finance

$412M Acquisition: SERB Pharmaceuticals Buys Cancer Drug Maker Y-mAbs at 105% Premium - Stock Titan

Geopolitics Watch: Is YMAB backed by strong institutional buying - Quarterly Profit Summary & Low Risk Growth Stock Ideas - baoquankhu1.vn

Advanced Charts

Top Gainers

Top Losers